|
LOC401397 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.267000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.572840E-01 |
| Normal-vs-Stage2 |
5.632200E-01 |
| Normal-vs-Stage3 |
5.230600E-01 |
| Normal-vs-Stage4 |
7.982800E-01 |
| Stage1-vs-Stage2 |
9.079800E-01 |
| Stage1-vs-Stage3 |
6.297000E-01 |
| Stage1-vs-Stage4 |
3.168800E-01 |
| Stage2-vs-Stage3 |
8.639600E-01 |
| Stage2-vs-Stage4 |
6.747400E-01 |
| Stage3-vs-Stage4 |
7.017400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.947200E-01 |
| Normal-vs-AfricanAmerican |
3.224500E-03 |
| Normal-vs-Asian |
5.357600E-02 |
| Caucasian-vs-AfricanAmerican |
1.821680E-02 |
| Caucasian-vs-Asian |
3.042200E-01 |
| AfricanAmerican-vs-Asian |
9.043600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.346800E-01 |
| Normal-vs-Female |
2.119400E-01 |
| Male-vs-Female |
6.696000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.414400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.884200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.519800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.242300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.546800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.909200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.037400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.845000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.845900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.222360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.569920E-02 |
| Normal-vs-Grade 2 |
7.373200E-01 |
| Normal-vs-Grade 3 |
5.596200E-01 |
| Normal-vs-Grade 4 |
1.047570E-02 |
| Grade 1-vs-Grade 2 |
1.695720E-02 |
| Grade 1-vs-Grade 3 |
1.488110E-02 |
| Grade 1-vs-Grade 4 |
5.352200E-01 |
| Grade 2-vs-Grade 3 |
8.778400E-01 |
| Grade 2-vs-Grade 4 |
3.734100E-02 |
| Grade 3-vs-Grade 4 |
2.658400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.042400E-01 |
| Normal-vs-ccB subtype |
9.380800E-03 |
| ccA subtype-vs-ccB subtype |
2.963800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.493400E-01 |
| Normal-vs-N1 |
4.590400E-01 |
| N0-vs-N1 |
6.714600E-01 |
|
|
